meRfi®-GM
Head & Neck squamous cell carcinoma (HNSCC)
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
The incidence of Head & Neck squamous cell carcinoma (HNSCC) is of nearly 500,000 new cases and 300,000 deaths annually
The majority of patients with locally advanced head and neck squamous cell carcinoma (HNSCC) will recur.
Head & Neck squamous cell carcinoma (HNSCC) is one of the most morbid of human cancers.
see also:
Oral Microbiome / Mouth Microbiota
…
References (Sources)
- Chronic periodontitis and the risk of head and neck squamous cell carcinoma: facts and figures
- Comparison of second-line treatments of recurrent and/or metastatic squamous cell carcinoma of the head and neckReview
- Curcumin Treatment Suppresses IKKß Kinase Activity of Salivary Cells of Patients with Head and Neck Cancer: A Pilot Study
- Immune escape mechanisms in head and neck squamous cell carcinoma and implication for new immunotherapy approach
- Integrin alpha 7 correlates with worse clinical features and prognosis, and its knockdown inhibits cell proliferation and stemness in tongue squamous cell carcinoma
- Optimizing treatments for recurrent or metastatic head and neck squamous cell carcinoma
- Things are changing for head and neck squamous cell carcinomas